Detalles de la búsqueda
1.
The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials.
Cardiovasc Drugs Ther
; 2022 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36194352
2.
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials.
Cardiovasc Drugs Ther
; 31(4): 391-400, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28856537
3.
The role of insulin therapy and glucose normalisation in patients with acute coronary syndrome.
Neth Heart J
; 19(2): 79-84, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21461038
4.
Encouraging survival rates in patients with acute myocardial infarction treated with an intra-aortic balloon pump.
Neth Heart J
; 19(3): 112-118, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21475411
5.
Process of care partly explains the variation in mortality between hospitals after peripheral vascular surgery.
Eur J Vasc Endovasc Surg
; 40(2): 147-54, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20547077
6.
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.
Cardiovasc Drugs Ther
; 23(2): 171-81, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19082699
7.
Variation between hospitals in patient outcome after stroke is only partly explained by differences in quality of care: results from the Netherlands Stroke Survey.
J Neurol Neurosurg Psychiatry
; 79(8): 888-94, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18208861
8.
[Differences between hospitals in outcome after a stroke are only partially explained by differences in the quality of care]. / Verschillen tussen ziekenhuizen in uitkomst na een herseninfarct vooral verklaard door patiëntkenmerken en slechts ten dele door verschillen in de kwaliteit van zorg.
Ned Tijdschr Geneeskd
; 152(39): 2126-32, 2008 Sep 27.
Artículo
en Holandés
| MEDLINE | ID: mdl-18856030
9.
Costs and benefits of treatment of myocardial infarction.
Neth Heart J
; 21(5): 228-9, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23572331
10.
[Guideline 'Cardiovascular Risk Management']. / Richtlijn 'cardiovasculair risicomanagement'.
Ned Tijdschr Geneeskd
; 151(19): 1068-74, 2007 May 12.
Artículo
en Holandés
| MEDLINE | ID: mdl-17552415
11.
Real-time transthoracic three-dimensional echocardiography provides additional information of left-sided AV valve morphology after AVSD repair.
Int J Cardiol
; 106(3): 360-4, 2006 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-16125812
12.
Angiographic findings in patients with refractory unstable angina according to troponin T status.
Circulation
; 100(14): 1509-14, 1999 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-10510053
13.
Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention.
Circulation
; 100(20): 2045-8, 1999 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-10562258
14.
Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial.
Circulation
; 107(3): 437-42, 2003 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-12551868
15.
Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Circulation
; 104(23): 2772-7, 2001 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-11733393
16.
Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Circulation
; 102(10): 1093-100, 2000 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-10973836
17.
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.
Circulation
; 102(10): 1101-6, 2000 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-10973837
18.
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.
Circulation
; 101(22): 2557-67, 2000 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-10840005
19.
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators.
Circulation
; 101(7): 751-7, 2000 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-10683348
20.
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators.
Circulation
; 99(18): 2371-7, 1999 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-10318656